Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort
ConclusionsKidney transplant is a safe treatment modality for children with ANCA-related kidney failure. ANCA patients have comparable graft survival when compared to the general transplant population with a low risk of recurrence. Thymoglobulin was used in a higher proportion within the ANCA group compared to the non-ANCA group. Tacrolimus, mycophenolate mofetil/mycophenolic acid, and steroids were the predominant maintenance immunosuppression used in both groups.Graphical abstractA higher resolution version of the Graphical abstract is available as Supplementary information.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Children | Kidney Transplant | Kidney Transplantation | Pediatrics | Prograf | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology | Vasculitis